Thiazolidinone Derivatives in Medicinal Applications

Thiazolidinone derivatives, characterised by a five-membered heterocyclic ring containing sulphur and nitrogen atoms, represent a versatile class of compounds in drug discovery. Their unique scaffold enables diverse functionalisation, granting access to a wide array of pharmacological activities. Recent medicinal chemistry efforts have harnessed variations in ring substitution, molecular hybridisation and conjugation with other heterocycles to target diseases ranging from cancer to metabolic disorders and infectious conditions. The capacity of these compounds to engage multiple biological targets—such as enzymes, nuclear receptors and signalling pathways—underpins their potential as multi-target agents. Synthetic innovations, including green chemistry routes and nanomaterial-assisted methods, have accelerated the generation of novel thiazolidinone libraries. Structure–activity relationship studies continue to refine potency and selectivity, illuminating the correlation between electronic features of the core ring and binding affinity. Clinically, thiazolidinediones have established efficacy in diabetes management, while newer derivatives are advancing preclinical studies in oncology, antimicrobial therapy and inflammatory diseases. Overall, thiazolidinone chemistry remains a dynamic frontier of translational research with global relevance.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Thiazolidinone Derivatives in Medicinal Applications publication trend

The graph below shows the total number of articles in thiazolidinone derivatives in medicinal applications across all publications each year (not limited to Nature Index journals).

Technical terms

Thiazolidinone: Five-membered heterocycle with sulphur and nitrogen atoms that serves as the core scaffold of studied compounds.

Scaffold: Central molecular framework to which functional groups are attached to confer biological activity.

Structure–activity relationship (SAR): Analysis correlating molecular modifications with changes in biological activity.

Molecular hybridisation: Strategy of combining two or more pharmacophores into one molecule to enhance efficacy or selectivity.

Peroxisome proliferator-activated receptor γ (PPARγ): Nuclear receptor regulating lipid metabolism, glucose homeostasis and cell differentiation.

Reactive oxygen species (ROS): Chemically reactive oxygen-containing molecules that can induce cellular stress or signalling.

NF-κB: Transcription factor that controls gene expression in inflammation, immune response and cell survival.

Cytotoxicity: Measure of a compound’s ability to kill or damage cells.

References

1. Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics. Cancer and Metastasis Reviews (2023).
2. Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines. Cells (2024).
3. Biological potential of thiazolidinedione derivatives of synthetic origin. BMC Chemistry (2017).